SEC Form 4/A · accession 0001013606-16-000221
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Christopher G. Chavez
Director
Period of report
Feb 29, 2016
Accepted (ET)
Apr 25, 2016 · 2:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Apr 25, 2016 | J | 328,586 | $0.00 | A | 355,540 | D | |
| Common SharesF1 | Feb 29, 2016 | J | 65,640 | $0.00 | A | 65,640 | I | Christopher G. Chavez Trustee of the Diana J Chavez Irrevocable Trust |
| Common SharesF1 | Feb 29, 2016 | J | 65,640 | $0.00 | A | 65,640 | I | Diana J Chavez of the Trustee of the Christopher G. Chavez Family Irrevocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued relate to the exchange of TriVascular, Inc shares for Endologix, Inc shares per Endologix, Inc's agreement to acquire TriVascular, Inc.
Remarks
This Form 4/A is being filed to report an additional 43,306 shares of ELGX shares owned by the reporting person as of February 29th, 2016, the date of the original Form 4. The additional shares reported herein were omitted do to administrative error.